Figure 4.
Figure 4. PFS and OS of PET-2+ patients in the H10 trial. PFS (A) and OS (B) in patients PET+ after 2×ABVD randomly assigned to either standard treatment with ABVD plus INRT or treatment with BEACOPPescalated plus INRT. esc, escalated. Reprinted from André et al6 with permission.

PFS and OS of PET-2+patients in the H10 trial. PFS (A) and OS (B) in patients PET+ after 2×ABVD randomly assigned to either standard treatment with ABVD plus INRT or treatment with BEACOPPescalated plus INRT. esc, escalated. Reprinted from André et al with permission.

Close Modal

or Create an Account

Close Modal
Close Modal